Evidence map›Paper›PMID 17237123›Full record

Trial reportJournal of medical genetics2007

Genetic enhancement of cognition in a kindred with cone-rod dystrophy due to RIMS1 mutation.

Sanjay M Sisodiya, Pamela J Thompson, Anna Need, Sarah E Harris, Michael E Weale, Susan E Wilkie, Michel Michaelides, Samantha L Free, Nicole Walley, Curtis Gumbs and 8 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of medical genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Ribbon Synapses and Retinal Disease: Review.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Sanjay M SisodiyaDepartment of Clinical and Experimental Epilepsy, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. sisodiya@ion.ucl.ac.uk
Pamela J Thompson
Anna Need
Sarah E Harris
Michael E Weale
Susan E Wilkie
Michel Michaelides
Samantha L Free
Nicole Walley
Curtis Gumbs
Dianne Gerrelli
Piers Ruddle
Lawrence J Whalley
John M Starr
David M Hunt
David B Goldstein
Ian J Deary
Anthony T Moore
University College London · GBDuke University · USUniversity of Edinburgh · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of Aberdeen · GB

Funding

Medical Research Council G9826762Medical Research Council G9900837Wellcome Trust
6 · The paper itself

Abstract

backgroundThe genetic basis of variation in human cognitive abilities is poorly understood. RIMS1 encodes a synapse active-zone protein with important roles in the maintenance of normal synaptic function: mice lacking this protein have greatly reduced learning ability and memory function.

objectiveAn established paradigm examining the structural and functional effects of mutations in genes expressed in the eye and the brain was used to study a kindred with an inherited retinal dystrophy due to RIMS1 mutation. MATERIALS AND

methodsNeuropsychological tests and high-resolution MRI brain scanning were undertaken in the kindred. In a population cohort, neuropsychological scores were associated with common variation in RIMS1. Additionally, RIMS1 was sequenced in top-scoring individuals. Evolution of RIMS1 was assessed, and its expression in developing human brain was studied.

resultsAffected individuals showed significantly enhanced cognitive abilities across a range of domains. Analysis suggests that factors other than RIMS1 mutation were unlikely to explain enhanced cognition. No association with common variation and verbal IQ was found in the population cohort, and no other mutations in RIMS1 were detected in the highest scoring individuals from this cohort. RIMS1 protein is expressed in developing human brain, but RIMS1 does not seem to have been subjected to accelerated evolution in man.

conclusionsA possible role for RIMS1 in the enhancement of cognitive function at least in this kindred is suggested. Although further work is clearly required to explore these findings before a role for RIMS1 in human cognition can be formally accepted, the findings suggest that genetic mutation may enhance human cognition in some cases.

Indexed as

CognitionFamilyGenetic EnhancementAdultAgedAged, 80 and overAnimalsBrainEvolution, MolecularEye AbnormalitiesFemaleGene Expression RegulationGTP-Binding ProteinsHumansMaleMiceGTP-Binding ProteinsNerve Tissue ProteinsRIMS1 protein, humanRims1 protein, mouseRNA, Messenger

Identifiers

PMID17237123
PMCPMC2740882
OpenAlexW2135334984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.